Queralt J, Castells I
Poult Sci. 1985 Dec;64(12):2362-7. doi: 10.3382/ps.0642362.
A pharmacokinetic study of sulfamethoxazole (SMZ) and trimethoprim (TMP) was carried out on Warren hens after intravenous (iv) dosage of 4:1, and oral administration of dosages of 5:1, and 2.5:1. The SMZ and TMP half-lives were 8.2 and 2.4 hr, respectively. The ratio between SMZ and TMP serum levels (S/T ratio), after iv administration of the 4:1 dosage, was approximately 20 and remained constant for only 1 hr, while after 5:1 and 2.5:1 oral dosages, the S/T ratio was 40 and 20, respectively, and remained invariable for 12 hr. The oral bioavailability of SMZ and TMP was .46 and .36, respectively. The apparently slower elimination of TMP from serum following oral administration should provide an extended duration of the synergistic antibacterial effect when this route of administration is employed. Finally, the 2.5:1 combination, after oral administration, resulted in an appropriate synergistic ratio (S/T ratio = 20:1) of the drugs in the serum.
对沃伦母鸡进行了磺胺甲恶唑(SMZ)和甲氧苄啶(TMP)的药代动力学研究,静脉注射剂量为4:1,口服剂量为5:1和2.5:1。SMZ和TMP的半衰期分别为8.2小时和2.4小时。静脉注射4:1剂量后,SMZ与TMP血清水平之比(S/T比)约为20,仅在1小时内保持恒定,而口服5:1和2.5:1剂量后,S/T比分别为40和20,并在12小时内保持不变。SMZ和TMP的口服生物利用度分别为0.46和0.36。口服给药后TMP从血清中消除明显较慢,采用该给药途径时应能延长协同抗菌作用的持续时间。最后,口服2.5:1组合后,血清中药物产生了合适的协同比(S/T比=20:1)。